Multistate operator iAnthus said Thursday it closed on the acquisition of a 100% equity interest in MPX New Jersey, a medical cannabis company in the state.
The deal helps pave the way for iAnthus, which has offices in Toronto and New York, to take advantage of New Jersey’s forthcoming recreational marijuana market.
New Jersey regulators approved the acquisition on Jan. 7, according to an iAnthus news release.
Control of the lucrative marijuana operation had been the subject of a legal proceeding.